Ana M. Pittella
Rio De Janeiro, RJ, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Assessing liver disease in cyanotic CHD using multiparametric MRI: a call to prevent future burden.
Journal: Cardiology in the young
Published: January 13, 2026
MRI-derived extracellular volume to assess liver fibrosis in patients with metabolic-associated steatotic liver disease.
Journal: Abdominal radiology (New York)
Published: March 01, 2025
Gut-related molecules as potential biomarkers in patients with decompensated cirrhosis.
Journal: Annals of hepatology
Published: March 28, 2024
How Cardiac Fibrosis Assessed via T1 Mapping Is Associated with Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease.
Journal: Journal of clinical medicine
Published: October 29, 2023
New Insights on the Mechanisms of Myocardial Injury in Hypertensive Patients With COVID-19.
Journal: Journal of clinical immunology
Published: December 21, 2022
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil.
Journal: Nature communications
Published: June 24, 2021
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.
Journal: Lancet (London, England)
Published: January 27, 2021
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.
Journal: Lancet (London, England)
Published: November 24, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026